FDA: No Authority to Accept FY14 User Fees
FDA Shuts the Door on NDAs, sNDAs
By Mari Serebrov
Thursday, October 3, 2013
Don’t bother to submit new drug and supplemental applications (NDAs) during the government shutdown, the FDA is telling drugmakers.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.